COVID-19 in the CT Scanner
SARS-CoV-2 virus found inside CT scanner used on high volume of patients with viral infection.
Even with all the disinfection protocols and social distancing guidelines in place, a recent event has shown that SARS-CoV-2 – the virus that causes COVID-19 – can infiltrate CT scanners used to image patients suspected of viral infection.
But, there’s a silver lining – the virus was contained to the machine’s inward airflow filter.
In an article published online Oct. 1 in European Radiology Experimental, providers from Italy detailed the discovery of SARS-CoV-2 RNA in the internal working components of one of their CT scanners that was used on a large number of COVID-19-positive patients.
“Our study found SARS-CoV-2 RNA only in the inward airflow filter. All other gantry sampling sites were free of SARS-CoV-2 RNA,” said Dr. João Matos from the University of Genoa in Italy. “These results are encouraging since this filter may act as a partial barrier to the virus.”
The scanner in question was used over 26 days in 180 consecutive exams for patients who were confirmed to be positive for the virus. The team led by Matos opened the gantry of their 16-slice CT scanner to see whether it was contaminated with the virus. They took samples from eight different components of the machine: gantry case, gantry motor, X-ray tube, X-ray tube filter, outflow fan, fan grid, detectors, and inward airflow filter.
They ran each sample through the RT-PCR test. Alongside looking for SARS-CoV-2, the team analyzed the samples for bacterial and fungal infections, as well. Based on the RT-PCR results, the only component with any evidence of SARS-CoV-2 was the inward airflow filter. Everything else was clean.
“Even after 26 days of intensive use, conventional sanitization measures were most probably successful in preventing large-scale contamination of the CT scanner,” the team said. “SARS-CoV-2 RNA was found internally in the CT gantry only in the inward airflow filter. All remaining CT gantry zones were devoid of SARS-CoV-2 RNA. No bacterial or fungal cultures were obtained from internal CT gantry sampling zones.”
For more coverage based on industry expert insights and research, subscribe to the Diagnostic Imaging e-newsletter here.
What is the Best Use of AI in CT Lung Cancer Screening?
April 18th 2025In comparison to radiologist assessment, the use of AI to pre-screen patients with low-dose CT lung cancer screening provided a 12 percent reduction in mean interpretation time with a slight increase in specificity and a slight decrease in the recall rate, according to new research.
The Reading Room: Racial and Ethnic Minorities, Cancer Screenings, and COVID-19
November 3rd 2020In this podcast episode, Dr. Shalom Kalnicki, from Montefiore and Albert Einstein College of Medicine, discusses the disparities minority patients face with cancer screenings and what can be done to increase access during the pandemic.
Can CT-Based AI Radiomics Enhance Prediction of Recurrence-Free Survival for Non-Metastatic ccRCC?
April 14th 2025In comparison to a model based on clinicopathological risk factors, a CT radiomics-based machine learning model offered greater than a 10 percent higher AUC for predicting five-year recurrence-free survival in patients with non-metastatic clear cell renal cell carcinoma (ccRCC).
Could Lymph Node Distribution Patterns on CT Improve Staging for Colon Cancer?
April 11th 2025For patients with microsatellite instability-high colon cancer, distribution-based clinical lymph node staging (dCN) with computed tomography (CT) offered nearly double the accuracy rate of clinical lymph node staging in a recent study.
